EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduced seasonal coronavirus incidence in high‐risk population groups during the COVID‐19 pandemic

Aliisa Heiskanen iD, Yannick Galipeau, Julian Little, Marc-André Langlois, Curtis L Cooper

Immunity, Inflammation and Disease · 2024

DOI: 10.1002/iid3.1342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2024. Verfasst von Aliisa Heiskanen und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, Seasons. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Epidemiological data on seasonal coronaviruses (sCoVs) may provide insight on transmission patterns and demographic factors that favor coronaviruses (CoVs) with greater disease severity. This study describes the incidence of CoVs in several high‐risk groups in Ottawa, Canada, from October 2020 to March 2022.

Methods

Serological assays quantified IgG and IgM antibodies to SARS‐CoV‐2, HCoV‐OC43, HCoV‐NL63, HCoV‐HKU1, and HCoV‐229E. Incident infections were compared between four population groups: individuals exposed to children, transit users, immunocompromised, and controls. Associations between antibody prevalence indicative of natural infection and demographic variables were assessed using regression analyses.

Results

Transit users and those exposed to children were at no greater risk of infection compared to the control group. Fewer infections were detected in the immunocompromised group ( p = .03). SARS‐CoV‐2 seroprevalence was greater in individuals with low income and within ethnic minorities.

Conclusions

Our findings suggest that nonpharmaceutical interventions intended to reduce SAR‐CoV‐2 transmission protected populations at high risk of exposure. The re‐emergence of sCoVs and other common respiratory viruses alongside SARS‐CoV‐2 may alter infection patterns and increase the risk in vulnerable populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2SeasonsHumansIncidenceMaleFemaleChildAdultMiddle AgedAdolescentAntibodies, ViralChild, PreschoolSeroepidemiologic StudiesYoung AdultAgedRisk FactorsCanadaInfantPandemicsImmunoglobulin GImmunoglobulin M

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2incidenceseasonal coronavirusseroprevalence

Substanzen

Antibodies, ViralImmunoglobulin GImmunoglobulin M

Autor:innen und Institutionen

  • School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Biochemistry, Microbiology & Immunology, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
  • Centre for Infection, Immunity and Inflammation (CI3), University of Ottawa, Ottawa, Ontario, Canada.
  • Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.

ORCID-Profile: Aliisa Heiskanen

Förderung

  • Canadian Institute of Health Research

Zitieren

APA

Heiskanen, A., Galipeau, Y., Little, J., Langlois, M. A., & Cooper, C. L. (2024). Reduced seasonal coronavirus incidence in high‐risk population groups during the COVID‐19 pandemic. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.1342

Vancouver

Heiskanen A, Galipeau Y, Little J, Langlois MA, Cooper CL. Reduced seasonal coronavirus incidence in high‐risk population groups during the COVID‐19 pandemic. Immunity, Inflammation and Disease. 2024. doi:10.1002/iid3.1342

BibTeX
@article{Heiskanen2024,
  author = {Heiskanen, Aliisa and Galipeau, Yannick and Little, Julian and Langlois, Marc-André and Cooper, Curtis L},
  title = {Reduced seasonal coronavirus incidence in high‐risk population groups during the COVID‐19 pandemic},
  journal = {Immunity, Inflammation and Disease},
  year = {2024},
  doi = {10.1002/iid3.1342}
}
Kostenlos starten →